objectives progression severity lung disease differs markedly early patients cystic fibrosis cf investigated hypothesis polymorphisms detoxifying enzymes gst influence phenotypic presentation lung disease cf methods genotypes gstm1 gstm3 gstp1 gstt1 determined cohort NUMBER children cf methods pulmonary function assessed spirometric measures forced expiratory volume second fev1 forced vital capacity fvc analysed children age NUMBER results association spirometric measurements gstm1 gstp1 gstt1 genotypes compared patients homozygous gstm3a allele cf children carrying gstm3b allele displayed significant better lung function assessed mean values fev1 fvc respectively p NUMBER p NUMBER correlations remained significant adjustment potential confounding factors respectively adjusted p NUMBER p NUMBER subgroups cf patients carry deltaf508 cftr mutation haplotype analysis gstm3 combination gstm1 indicated positive impact gstm3b allele pulmonary performances barely influenced gstm1 genotypes cf children conclusions data provide evidence suggesting polymorphism gstm3 gene contributes clinical severity cf prognostic significance prompt start targeted therapy young patients cf copyright NUMBER lippincott williams wilkins glutathione s transferase pcr based